N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope protein gp41, is an activator of human phagocytes

Clinical Immunology

Volumn 96, Issue 3, 2000, Pages 236-242

  Le, Yingying ^a   Jiang, Shibo ^b   Hu, Jinyue ^a   Gong, Wanghua ^a   Su, Shaobo ^a   Dunlop, Nancy M ^a   Shen, Weiping ^a   Li, Baoqun ^a   Ming Wang, Ji ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NEW YORK BLOOD CENTER   (United States)

Author keywords

Chemoattractant receptor; HIV 1 gp 41; N36 peptide; Phagocyte

Indexed keywords

CALCIUM; CHEMOKINE RECEPTOR; CHEMOTACTIC PEPTIDE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN GP 41; SYNTHETIC PEPTIDE; VIRUS ENVELOPE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO TERMINAL SEQUENCE; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION;

EID: 0033848603     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2000.4896     Document Type: Article

References (37)

1. HIV entry and its inhibition
2. The HIV-cell fusion reaction
3. HIV-1 inhibition by a peptide
4. Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection
5. A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition
6. A trimeric structural domain of the HIV-1 transmembrane glycoprotein
7. A trimeric structural subdomain of the HIV-1 transmembrane glycoprotein
8. Core structure of gp41 from the HIV-envelope glycoprotein
9. Atomic structure of a thermostable subdomain of HIV-1 gp41
10. Atomic structure of the ectodomain from HIV-1 gp41
11. HIV-1 gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes
12. HIV-1 envelope gp120 inhibits monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation
13. Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis
14. T20/DP178, an ectodomain peptide of human immunodeficiency virus type 1 gp41, is an activator of human phagocyte N-formyl peptide receptor
15. The N-formyl peptide chemotactic receptors
16. The N-formyl peptide receptor: A model for the study of chemoattractant receptor structure and function
17. T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G protein-coupled formal peptide receptors
18. Properties of the novel proinflammatory supergene 'intercrine' cytokine family
19. A seven-transmembrane, G-protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells
20. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway
21. Serum amyloid A is a chemoattractant: Induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes
22. A synthetic peptide derived from HIV-1 gp120 down-regulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the seven-transmembrane G protein-coupled receptor FPRL1/LXA4R
23. Virus-induced neutrophil dysfunction: Role in the pathogenesis of bacterial infections
24. Impaired neutrophil function in patients with AIDS or AIDS-related complex: A comprehensive evaluation
25. Reduced expression of interleukin-8 receptors A and B on polymorphonuclear neutrophils from persons with human immunodeficiency virus type 1 disease and pulmonary tuberculosis
26. Defective polymorphonuclear leukocyte chemotaxis in homosexual men with persistent lymph node syndrome
27. Depressed neutrophils superoxide production in human immunodeficiency virus infection
28. Dysregulation of the polymorphonuclear leukocyte-Candida spp. interaction in HIV-positive patients
29. HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes
30. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins
31. Neutralization of HIV-1: A paradox of humoral proportions
32. Decline of anti-DP107 antibody associated with clinical progression
33. Effect of human immunodeficiency virus type 1 on intracellular activation and superoxide production by neutrophils
34. Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome
35. Depressed phagocytosis and oxidative burst in polymorphonuclear leukocytes from individuals with pulmonary tuberculosis with or without human immunodeficiency virus type 1 infection
36. Lineage-specific expression of human immunodeficiency virus (HIV) receptor/coreceptors in differentiating hematopoietic precursors: Correlation with susceptibility to T- and M-tropic HIV and chemokine-mediated HIV resistance
37. Human chemotaxis receptor genes cluster at 19q13.3-13.4. Characterization of the human C5a receptor gene